We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Anna MacDonald

Anna MacDonald

Senior Science Editor


After obtaining a first-class honours degree in biological sciences from the University of East Anglia, Anna worked as a scientific conference producer before joining Technology Networks. As part of her role, Anna helps to coordinate coverage, working with key opinion leaders from industry and academia to produce content across all communities.


Got a question for Anna MacDonald?


Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 312
A Paradigm Shift in Sepsis Diagnostics  content piece image
Industry Insight

A Paradigm Shift in Sepsis Diagnostics

In this interview, Rolland Carlson, PhD, CEO of Immunexpress, discusses sepsis and the company’s FDA cleared SeptiCyte® RAPID test, as well as a take on the company’s differentiated value and outlook.
What Does the Endocannabinoid System Have To Do With Autism Spectrum Disorder? content piece image
Article

What Does the Endocannabinoid System Have To Do With Autism Spectrum Disorder?

To learn more about the link between endocannabinoids and ASD and how innovative models are helping to study the ECS and its effects on the developing brain, Technology Networks spoke to Drs. Karen Litwa and Ken Soderstrom from East Carolina University.
Digitalization of the Lab: Benefits, Solutions and the Future content piece image
Industry Insight

Digitalization of the Lab: Benefits, Solutions and the Future

To learn more about how digitalization can benefit workflows in the lab and some of the innovative solutions that Eppendorf offers in this area, Technology Networks spoke to Ann-Claire Foetsch.
Unlocking the Functional Antibody Repertoire content piece image
Industry Insight

Unlocking the Functional Antibody Repertoire

Technology Networks learns about serum epitope repertoire analysis and some of the applications it could benefit, including cancer diagnostics and COVID-19 studies.
Developing a Sustainable Source of Squalene content piece image
Industry Insight

Developing a Sustainable Source of Squalene

Technology Networks spoke to Jason Ornstein and Barry Holtz to learn how Synshark and Phylloceuticals are working together to address current challenges associated with squalene supply and access.

Developing Therapeutics for Huntington’s Disease: Challenges, Opportunities and the Future content piece image
Industry Insight

Developing Therapeutics for Huntington’s Disease: Challenges, Opportunities and the Future

Dr. Christian Landles explains why it is so challenging to develop therapeutics for rare diseases such as HD, and discusses the potential of approaches that target mutant huntingtin protein to improve treatment options for HD patients.
Driving Forward Huntington’s Disease Research content piece image
Industry Insight

Driving Forward Huntington’s Disease Research

Dr. Christian Landles highlights some of the progress made in recent years to improve our understanding of HD and its drivers.
New Model Will Support Drug Discovery for Liver Disease NASH content piece image
Industry Insight

New Model Will Support Drug Discovery for Liver Disease NASH

To learn more about NASH “in-a-box” and how it can help to advance drug discovery for NASH, Technology Networks spoke to Dr. Audrey Dubourg.
Harnessing the Potential of Bioelectronic Medicine To Treat Essential Tremors content piece image
Industry Insight

Harnessing the Potential of Bioelectronic Medicine To Treat Essential Tremors

Technology Networks spoke to Renee Ryan, Cala Health's CEO, to learn more about bioelectronic medicine and its use as a therapy for essential tremors.
Probing the Proteome With Engineered Nanoparticles content piece image
Industry Insight

Probing the Proteome With Engineered Nanoparticles

In this interview, Dr. Daniel Hornburg discusses how engineered nanoparticles could help to bridge the gap between proteomics and genomics and transform cancer diagnostics.
Advertisement